Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Remogliflozin etabonate | 442201-24-3 | 99.6% | 522.59 | 50 MG
Supplier: Medchemexpress LLC HY1494550MG
Remogliflozin etabonate is an orally active, selective, and low-affinity sodium glucose cotransporter (SGLT2) inhibitor. It acts as a proagent, based on benzylpyrazole glucoside, and is metabolized in the body to its active form, Remogliflozin. This compound has demonstrated antidiabetic efficacy in rodent models.
- Orally active and selective SGLT2 inhibitor
- Metabolized to active form, Remogliflozin
- Demonstrates antidiabetic efficacy in rodent models
- Ki values for hSGLT2, rSGLT2, hSGLT1, and rSGLT1
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?